At ResMed, we’re focused on developing our industry and patient expertise in sleep and respiratory disorders. That’s why we continue to research areas related to sleep-disordered breathing.
We believe that industry and medical science need to work together to enhance medicine and patient therapy.
Consult our numerous research and clinical papers below.
ResMed is a global pioneer and leader in sleep and respiratory disorders. All about our research on sleep-disordered breathing and related innovation and technology.
Sleep disordered breathing and mandibular repositioning devices
There’s a growing body of clinical research that demonstrates the efficacy and compliance of mandibular repositioning devices (MRDs) in treating osbstructive sleep apnoea and snoring. The following clinical research papers demonstrate results in particular for ResMed’s Narval CC™ MRD.
ResMed is committed to researching the association between sleep apnoea and cardiovascular issues. All about our research on sleep and cardiology, specifically on heart failure and CSA-CSR.
At ResMed, we provide a number of solutions to treat respiratory disorders. Noninvasive ventilation (NIV) can used to treat patients with respiratory dysfunction. All about respiratory care and NIV.
At ResMed, we’re focused on improving patient compliance. That’s why we continue to develop ventilators around iVAPS algorithms, an innovative technology that adapts to patients.
Farrell historical landmarks
ResMed Founder and Chairman Dr. Peter Farrell identifies key research findings that are shaping the field of sleep medicine today.
Sleep apnoea and digital connected health
Recent research findings show the positive effects of connected health on the treatment of sleep apnoea patients.